Journal for ImmunoTherapy of Cancer (Nov 2020)

809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival

  • Trisha Wise-Draper,
  • Diana Bell,
  • Roman Jandarov,
  • Shuchi Gulati,
  • Maura Gillison,
  • Vinita Takiar,
  • Sarah Palackdharry,
  • Francis Worden,
  • Matthew Old,
  • John Kaczmar,
  • Neal Dunlap,
  • Benjamin Hinrichs,
  • Yash Patil,
  • Muhammad Kashif Riaz,
  • Layne Weatherford,
  • Aubrey Hamilton,
  • Sheena Lanverman,
  • Michelle Mierzwa,
  • Keith Casper,
  • Jonathan Mark,
  • Alice Tang,
  • Chad Zender,
  • Ann Gillenwater,
  • Mario Medvedovich,
  • J Jack Lee

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0809
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.